197,957 Shares in Molina Healthcare, Inc $MOH Purchased by Deutsche Bank AG

Deutsche Bank AG acquired a new stake in shares of Molina Healthcare, Inc (NYSE:MOH) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 197,957 shares of the company’s stock, valued at approximately $45,273,000.

Several other large investors have also recently modified their holdings of the business. Elevation Wealth Partners LLC increased its stake in Molina Healthcare by 118.2% in the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock valued at $33,000 after acquiring an additional 78 shares during the last quarter. Torren Management LLC purchased a new stake in shares of Molina Healthcare in the 4th quarter valued at $26,000. MUFG Securities EMEA plc purchased a new position in Molina Healthcare in the 2nd quarter worth $48,000. Global Retirement Partners LLC bought a new stake in Molina Healthcare in the second quarter worth $39,000. Finally, Quarry LP purchased a new stake in Molina Healthcare during the fourth quarter valued at about $32,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on MOH shares. Cantor Fitzgerald reiterated a “neutral” rating on shares of Molina Healthcare in a report on Friday, July 24th. Truist Financial dropped their price target on shares of Molina Healthcare from $250.00 to $225.00 and set a “hold” rating for the company in a research report on Friday, July 24th. Mizuho set a $215.00 price objective on shares of Molina Healthcare in a research report on Monday, June 8th. Bank of America raised shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective for the company in a research note on Wednesday, April 29th. Finally, Zacks Research upgraded Molina Healthcare from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 23rd. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, Molina Healthcare presently has a consensus rating of “Hold” and a consensus price target of $202.44.

Molina Healthcare Stock Performance

Shares of MOH opened at $200.63 on Friday. Molina Healthcare, Inc has a 52 week low of $121.06 and a 52 week high of $244.89. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.95. The stock has a market cap of $10.47 billion, a P/E ratio of -1,114.55, a P/E/G ratio of 28.22 and a beta of 0.75. The business’s 50 day moving average price is $211.25 and its 200-day moving average price is $178.58.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, topping the consensus estimate of $1.39 by $0.12. The business had revenue of $10.87 billion for the quarter, compared to the consensus estimate of $10.83 billion. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The company’s revenue for the quarter was down 4.8% compared to the same quarter last year. During the same period in the previous year, the company posted $5.48 earnings per share. Equities research analysts anticipate that Molina Healthcare, Inc will post 5.29 earnings per share for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.